Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Shoaib Faruqi, Sean Zhou, Joanne Thompson, Terry Robinson, Karen Watkins, Helena Cummings, Nicola Jackson, Anoop Prakash, Michael Crooks. Suppression of F_ENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?. ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019

Member's Comments

No comment yet.

Related content which might interest you: FENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma Source: Eur Respir J, 55 (5) 2001319; 10.1183/13993003.01319-2020 Year: 2020 Pulmonary function test changes after cessation of inhaled corticosteroid therapy in asthma patients Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 Clinical utility of measuring FeNO to assess inhaled corticosteroid response in asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Is sputum eosinophilia a good or poor predictor of benefit from inhaled corticosteroid therapy in asthma? Source: Eur Respir J 2002; 20: 1359-1361 Year: 2002 Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Source: Eur Respir J 2006; 28: Suppl. 50, 319s Year: 2006 Is there a problem with inhaled corticosteroid use in COPD? Source: Virtual Congress 2020 – Airway diseases Year: 2020 Inhaled steroids as an intervention on long-term outcome of cough variant asthma Source: Eur Respir J 2001; 18: Suppl. 33, 97s Year: 2001 Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010 Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006 Control of persistent asthma patients on inhaled corticosteroids in a real-life setting Source: Annual Congress 2010 - New insights in the epidemiology of asthma Year: 2010 Children with mild asthma: do they benefit from inhaled corticosteroids? Source: Eur Respir J 2002; 20: 1470-1475 Year: 2002 Does acute bronchodilator test is predictive of inhaled corticosteroid response in COPD/asthma patients? Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 Mild asthma. Is constant therapy by inhaled steroids necessary? Source: Eur Respir J 2006; 28: Suppl. 50, 500s Year: 2006 Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019 Year: 2020 Is GLCCI1 associated with response to inhaled corticosteroids in asthma patients? Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 High or standard initial dose of budesonide to control mild-to-moderate asthma? Source: Eur Respir J 2001; 17: 856-862 Year: 2001 Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Utility of high dose inhaled fluticasone therapy for the early management of acute exacerbations of asthma Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009